Immuno-stimulatory effect of levamisole in borderline leprosy cases.
Eleven cases of borderline-borderline leprosy were subjected to levamisole therapy for 3 months. Levamisole was given 150 mg/day on three consecutive days every fortnight along with dapsone (DDS). Immuno-stimulation was assessed by lepromin test using Lepromin-A supplied by W.H.O. containing 4.0 X 10(7) bacilli per milli litre. It was found that there was statistically significant change in lepromin reaction after levamisole therapy.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007916:Lepromin / Q000276:immunology; D007918:Leprosy / Q000276:immunology*; D007978:Levamisole / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
D000276:Adjuvants, Immunologic; D007916:Lepromin; D007978:Levamisole